SCHEMBL19255555

SCHEMBL19255555

Nc1nc(-c2n[nH]c3c(F)cncc23)ncc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19255752 0.82 CHEK1 (0.36)
SCHEMBL19255693 0.82 EGFR (0.31)
SCHEMBL19255178 0.80 MAPK1 (0.31)
SCHEMBL19249768 0.77 TGFBR1 (0.35)
SCHEMBL9977698 0.73 PIK3CG (0.35)
SCHEMBL9977719 0.72 ATR (0.34)
SCHEMBL19250804 0.71 NOS3 (0.33)
SCHEMBL19250682 0.71 SGK1 (0.33)
SCHEMBL19244048 0.70
SCHEMBL19250685 0.68 SGK1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017133670-A1 PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATMENT, AMELIORATION OR PREVENTION OF INFLUENZA SAVIRA PHARMACEUTICALS GMBH (AT) 2017-08-10 WO disclosed